In 2004, a groundbreaking discovery came from a research group of Mayo Clinic that showed the presence of AQP4-IgG in the serum of patients who previously had “atypical” MS that exclusively presented recurrent ON and/or myelitis (1, 2). This evidence concerns the gene AQP4 and myelitis.